Zobrazeno 1 - 9
of 9
pro vyhledávání: '"59"'
Autor:
Doron Zahger, Shlomi Matetzky, Bojan Cercek, Marko Noc, Prediman K. Shah, Peter R. Mahrer, Gerald Maurer, Uwe Zeymer
Publikováno v:
The Lancet. 361:809-813
Summary Background There is serological and epidemiological evidence of an association between Chlamydia pneumoniae infection and coronary artery disease. Results of previous smaller studies have indicated a reduction of recurrent ischaemic events in
Autor:
Colin P, Derdeyn, Marc I, Chimowitz, Michael J, Lynn, David, Fiorella, Tanya N, Turan, L Scott, Janis, Jean, Montgomery, Azhar, Nizam, Bethany F, Lane, Helmi L, Lutsep, Stanley L, Barnwell, Michael F, Waters, Brian L, Hoh, J Maurice, Hourihane, Elad I, Levy, Andrei V, Alexandrov, Mark R, Harrigan, David, Chiu, Richard P, Klucznik, Joni M, Clark, Cameron G, McDougall, Mark D, Johnson, G Lee, Pride, John R, Lynch, Osama O, Zaidat, Zoran, Rumboldt, Harry J, Cloft, I, Fleming
Publikováno v:
The Lancet. 383:333-341
Summary Background Early results of the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14·7%) of 224 patients in the stenting group and 13 (5·8%) of 227 patient
Autor:
Lisa Porter, Sylvia K. Shenouda, Guntram Schernthaner, Mark Fineman, Cory R. Heilmann, Michael A. Nauck, Aijun Gao, Thomas Forst, Wayne Huey-Herng Sheu, John B. Buse, Byron J. Hoogwerf, Marilyn K. Boardman
Publikováno v:
The Lancet. 381:117-124
Glucagon-like peptide-1 receptor agonists exenatide and liraglutide have been shown to improve glycaemic control and reduce bodyweight in patients with type 2 diabetes. We compared the efficacy and safety of exenatide once weekly with liraglutide onc
Autor:
K Shimada, Susumu Yamasaki, Masatoshi Makuuchi, Tadao Kakizoe, Tomoo Kosuge, Junji Yamamoto, Teruaki Sekine, Tadatoshi Takayama, Michiie Sakamoto, Yasuo Ohashi, Setsuo Hirohashi
Publikováno v:
The Lancet. 356:802-807
Summary Background Postsurgical recurrence of hepatocellular carcinoma (HCC) is frequent and fatal. Adoptive immunotherapy is active against HCC. We assessed whether postoperative immunotherapy could lower the frequency of recurrence. Methods Between
Publikováno v:
The Lancet. 353:1819-1823
Little is known about the long-term efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD). We investigated the efficacy of inhaled budesonide on decline in lung function and respiratory symptoms in a 3-year placebo-contr
Autor:
Grace L. Lu-Yao, Siu-Long Yao
Publikováno v:
The Lancet. 349:906-910
Summary Background Choice of treatment in localised prostate cancer has been hampered by a lack of unbiased, representative data on outcome. Most existing data have come from small cohorts at specialised academic centres; precise overall and cancer-g
Publikováno v:
The Lancet. 345:1392-1397
Interferon-alpha may be better than cytotoxic drugs in the long-term management of patients with chronic myeloid leukaemia (CML) in chronic phase. To test this possibility 587 patients with CML in chronic phase were randomly allocated to receive lymp
Autor:
Laurence Moore, Joanne Holliday, Suzanne Audrey, Rachael A. Hughes, N. Parry-langdon, Michael Bloor, Rona Campbell, F. Starkey
Publikováno v:
The Lancet. (9624):1595-1602
Background Schools in many countries undertake programmes for smoking prevention, but systematic reviews have shown mixed evidence of their effectiveness. Most peer-led approaches have been classroom-based, and rigorous assessments are scarce. We ass
Publikováno v:
The Lancet.
Summary Background Progesterone administration has been shown to reduce the risk of preterm birth and neonatal morbidity in women at high risk, but there is uncertainty about longer term effects on the child. Methods We did a double-blind, randomised